These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 31539061)

  • 1. Impact of adding tacrolimus to initial treatment of interstitial pneumonitis in polymyositis/dermatomyositis: a single-arm clinical trial.
    Takada K; Katada Y; Ito S; Hayashi T; Kishi J; Itoh K; Yamashita H; Hirakata M; Kawahata K; Kawakami A; Watanabe N; Atsumi T; Takasaki Y; Miyasaka N
    Rheumatology (Oxford); 2020 May; 59(5):1084-1093. PubMed ID: 31539061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of tacrolimus in patients with refractory dermatomyositis/polymyositis: a systematic review.
    Ge Y; Zhou H; Shi J; Ye B; Peng Q; Lu X; Wang G
    Clin Rheumatol; 2015 Dec; 34(12):2097-103. PubMed ID: 26328518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis.
    Kurita T; Yasuda S; Oba K; Odani T; Kono M; Otomo K; Fujieda Y; Oku K; Bohgaki T; Amengual O; Horita T; Atsumi T
    Rheumatology (Oxford); 2015 Jan; 54(1):39-44. PubMed ID: 24764266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and risk of interstitial lung disease in dermatomyositis and polymyositis: a retrospective cohort study in Japan.
    Hu Q; Huang KC; Goh CH; Tsuchiya Y; Liu Y; Qiu H
    Sci Rep; 2023 Oct; 13(1):17172. PubMed ID: 37821555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of serum markers for the development of interstitial lung disease in patients with polymyositis and dermatomyositis: a comparative and prospective study.
    Chen F; Lu X; Shu X; Peng Q; Tian X; Wang G
    Intern Med J; 2015 Jun; 45(6):641-7. PubMed ID: 25827843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective Use of Calcineurin Inhibitor in Combination Therapy for Interstitial Lung Disease in Patients With Dermatomyositis and Polymyositis.
    Shimojima Y; Ishii W; Matsuda M; Kishida D; Ikeda SI
    J Clin Rheumatol; 2017 Mar; 23(2):87-93. PubMed ID: 28225510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticosteroid-sparing effect of tacrolimus in the initial treatment of dermatomyositis and polymyositis.
    Yokoyama Y; Furuta S; Ikeda K; Hirose K; Nakajima H
    Mod Rheumatol; 2015; 25(6):888-92. PubMed ID: 25775144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine.
    Nawata Y; Kurasawa K; Takabayashi K; Miike S; Watanabe N; Hiraguri M; Kita Y; Kawai M; Saito Y; Iwamoto I
    J Rheumatol; 1999 Jul; 26(7):1527-33. PubMed ID: 10405940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advantage of administering tacrolimus for improving prognosis of patients with polymyositis and dermatomyositis.
    Ueno KI; Shimojima Y; Kishida D; Sekijima Y; Ikeda SI
    Int J Rheum Dis; 2016 Dec; 19(12):1322-1330. PubMed ID: 27457756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis.
    Fujisawa T; Suda T; Nakamura Y; Enomoto N; Ide K; Toyoshima M; Uchiyama H; Tamura R; Ida M; Yagi T; Yasuda K; Genma H; Hayakawa H; Chida K; Nakamura H
    J Rheumatol; 2005 Jan; 32(1):58-64. PubMed ID: 15630726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis.
    Kameda H; Nagasawa H; Ogawa H; Sekiguchi N; Takei H; Tokuhira M; Amano K; Takeuchi T
    J Rheumatol; 2005 Sep; 32(9):1719-26. PubMed ID: 16142867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab therapy in patients with refractory dermatomyositis or polymyositis: differential effects in a real-life population.
    Unger L; Kampf S; Lüthke K; Aringer M
    Rheumatology (Oxford); 2014 Sep; 53(9):1630-8. PubMed ID: 24706995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transbronchial biopsy is clinically useful in classifying patients with interstitial pneumonia associated with polymyositis and dermatomyositis.
    Mochimaru H; Kawamoto M; Enomoto T; Saitoh Y; Abe S; Nei T; Fukuda Y; Kudoh S
    Respirology; 2008 Nov; 13(6):863-70. PubMed ID: 18811885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coadministration of tacrolimus with corticosteroid accelerates recovery in refractory patients with polymyositis/ dermatomyositis: a retrospective study.
    Shimojima Y; Ishii W; Matsuda M; Tazawa K; Ikeda S
    BMC Musculoskelet Disord; 2012 Nov; 13():228. PubMed ID: 23173570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of calcineurin inhibitors for the treatment of interstitial lung disease associated with polymyositis/dermatomyositis.
    Kurita T; Yasuda S; Amengual O; Atsumi T
    Lupus; 2015 Jan; 24(1):3-9. PubMed ID: 25297551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymyositis/dermatomyositis and interstitial lung disease: a new therapeutic approach with T-cell-specific immunosuppressants.
    Takada K; Nagasaka K; Miyasaka N
    Autoimmunity; 2005 Aug; 38(5):383-92. PubMed ID: 16227154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of treatment on survival in polymyositis and dermatomyositis. A single-centre long-term follow-up study.
    Danieli MG; Gambini S; Pettinari L; Logullo F; Veronesi G; Gabrielli A
    Autoimmun Rev; 2014 Oct; 13(10):1048-54. PubMed ID: 25183232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymyositis and dermatomyositis in Sarawak: a profile of patients treated in the Sarawak General Hospital.
    Teh CL; Wong JS; Soo HH
    Rheumatol Int; 2012 Jan; 32(1):265-8. PubMed ID: 21243497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine treatment for polymyositis/dermatomyositis: is it possible to rescue the deteriorating cases with interstitial pneumonitis?
    Maeda K; Kimura R; Komuta K; Igarashi T
    Scand J Rheumatol; 1997; 26(1):24-9. PubMed ID: 9057798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and predictive factors for malignancies in 136 Japanese patients with dermatomyositis, polymyositis and clinically amyopathic dermatomyositis.
    Azuma K; Yamada H; Ohkubo M; Yamasaki Y; Yamasaki M; Mizushima M; Ozaki S
    Mod Rheumatol; 2011 Apr; 21(2):178-83. PubMed ID: 20922453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.